Literature DB >> 24121971

Impact of radiofrequency catheter ablation on echocardiographic and cardiopulmonary performance in patients with ventricular extrasystolic beats and suspected arrhythmia-induced cardiomyopathy.

Tomasz Krynski1, Sebastian Stec, Sebastian Szmit, Beata Zaborska, Paweł Balsam, Piotr Kulakowski, Grzegorz Opolski.   

Abstract

Integrated backscatter intravascular ultrasound (IB-IVUS) is a useful method for analyzing coronary plaque tissue. We evaluated whether tissue composition determined using IB-IVUS is associated with the progression of stenosis in coronary angiography. Sixty-three nontarget coronary lesions in 63 patients with stable angina were evaluated using conventional IVUS and IB-IVUS. IB-IVUS images were analyzed at 1-mm intervals for a length of 10 mm. After calculating the relative areas of the tissue components using the IB-IVUS system, fibrous volume (FV) and lipid volume (LV) were calculated through integration of the slices, after which percentages of per-plaque volume (%FV/PV, %LV/PV) and per-vessel volume (%FV/VV, %LV/VV) were calculated. Progression of coronary stenosis was interpreted from the increase in percent diameter stenosis (%DS) from baseline to the follow-up period (6–9 months) using quantitative coronary angiography. %DS was 24.1 ± 12.8 % at baseline and 23.2 ± 13.7 % at follow-up. Using IB-IVUS, LV was 31.7 ± 10.5 mm3, and %LV/PV and %LV/VV were 45.6 ± 10.3 % and 20.2 ± 6.0 %, respectively. FV, %FV/PV, and %FV/VV were 35.5 ± 12.1 mm3, 52.1 ± 9.5 %, and 23.4 ± 7.1 %, respectively. The change in %DS was −0.88 ± 7.25 % and correlated closely with %LV/VV (r = 0.27, P = 0.03) on simple regression. Multivariate regression after adjustment for potentially confounding risk factors showed %LV/VV to be correlated independently with changes in %DS (r = 0.42, P = 0.02). Logistic regression analysis after adjusting for confounding coronary risk factors showed LV (odds ratio 1.08; 95 % confidence interval 1.01–1.16; P = 0.03) and %LV/VV (odds ratio 1.13; 95 % confidence interval 1.01–1.28; P = 0.03) to be independent predictors of the progression of angiographic coronary stenosis. Our findings suggest that angiographic luminal narrowing of the coronary artery is likely associated with tissue characteristics. IB-IVUS may provide information about the natural progression of luminal narrowing in coronary stenosis.

Entities:  

Mesh:

Year:  2014        PMID: 24121971     DOI: 10.1007/s00380-013-0417-z

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  30 in total

1.  Ventilatory efficiency during exercise in healthy subjects.

Authors:  Xing-Guo Sun; James E Hansen; Nuria Garatachea; Thomas W Storer; Karlman Wasserman
Journal:  Am J Respir Crit Care Med       Date:  2002-12-01       Impact factor: 21.405

2.  An animal model for ectopy-induced cardiomyopathy.

Authors:  Nazem W Akoum; Marcos Daccarett; Stephen L Wasmund; Mohamed H Hamdan
Journal:  Pacing Clin Electrophysiol       Date:  2010-11-11       Impact factor: 1.976

3.  Suppression of frequent premature ventricular contractions and improvement of left ventricular function in patients with presumed idiopathic dilated cardiomyopathy.

Authors:  D F Duffee; W K Shen; H C Smith
Journal:  Mayo Clin Proc       Date:  1998-05       Impact factor: 7.616

4.  Left ventricular systolic dysfunction induced by ventricular ectopy: a novel model for premature ventricular contraction-induced cardiomyopathy.

Authors:  Jose F Huizar; Karoly Kaszala; Jonathan Potfay; Anthony J Minisi; Edward J Lesnefsky; Antonio Abbate; Eleonora Mezzaroma; Qun Chen; Rakesh C Kukreja; Nicholas N Hoke; Leroy R Thacker; Kenneth A Ellenbogen; Mark A Wood
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-05-16

5.  Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Authors:  Jeffrey A Towbin; April M Lowe; Steven D Colan; Lynn A Sleeper; E John Orav; Sarah Clunie; Jane Messere; Gerald F Cox; Paul R Lurie; Daphne Hsu; Charles Canter; James D Wilkinson; Steven E Lipshultz
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

6.  Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias: the incidence, clinical and electrophysiologic characteristics, and the predictors.

Authors:  Can Hasdemir; Cem Ulucan; Oguz Yavuzgil; Alper Yuksel; Yildirim Kartal; Evrim Simsek; Oktay Musayev; Meral Kayikcioglu; Serdar Payzin; Hakan Kultursay; Mehmet Aydin; Levent H Can
Journal:  J Cardiovasc Electrophysiol       Date:  2011-01-14

7.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

8.  Effects of catheter ablation of idiopathic ventricular ectopic beats on left ventricular function and exercise capacity.

Authors:  Jacek Lelakowski; Adam Dreher; Jacek Majewski; Jacek Bednarek
Journal:  Kardiol Pol       Date:  2009-08       Impact factor: 3.108

9.  Left ventricular size determines tissue Doppler-derived longitudinal strain and strain rate.

Authors:  Assami Rösner; Bart Bijnens; Magna Hansen; Ole Jakob How; Erling Aarsaether; Stig Müller; George R Sutherland; Truls Myrmel
Journal:  Eur J Echocardiogr       Date:  2008-09-30

10.  Improvement in non-tachycardia-induced cardiac failure after radiofrequency catheter ablation in a child with a right-sided accessory pathway.

Authors:  Hideo Fukunaga; Katsumi Akimoto; Takeshi Furukawa; Ken Takahashi; Masahiko Kishiro; Toshiaki Shimizu; Hiroshi Kamiyama; Naokata Sumitomo
Journal:  Heart Vessels       Date:  2013-02-13       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.